Document Detail


Bioengineered probiotics, a strategic approach to control enteric infections.
MedLine Citation:
PMID:  23327986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Enteric infections account for high morbidity and mortality and are considered to be the fifth leading cause of death at all ages worldwide. Seventy percent of all enteric infections are foodborne. Thus significant efforts have been directed toward the detection, control and prevention of foodborne diseases. Many antimicrobials including antibiotics have been used for their control and prevention. However, probiotics offer a potential alternative intervention strategy owing to their general health beneficial properties and inhibitory effects against foodborne pathogens. Often, antimicrobial probiotic action is non-specific and non-discriminatory or may be ineffective. In such cases, bioengineered probiotics expressing foreign gene products to achieve specific function is highly desirable. In this review we summarize the strategic development of recombinant bioengineered probiotics to control enteric infections, and to examine how scientific advancements in the human microbiome and their immunomodulatory effects help develop such novel and safe bioengineered probiotics.
Authors:
Mary Anne Roshni Amalaradjou; Arun K Bhunia
Related Documents :
23034326 - Carbapenemases in klebsiella pneumoniae and other enterobacteriaceae: an evolving crisi...
24012946 - Insights into fungal pathogenesis from the iatrogenic epidemic of exserohilum rostratum...
17526826 - Aspergillus flavus: human pathogen, allergen and mycotoxin producer.
24140976 - Malaria proteomics: insights into the parasite-host interactions in the pathogenic space.
17210976 - Comparison of an in-house and a commercial rd1-based elispot-ifn-gamma assay for the di...
15940516 - How predictable is the abundance of double gametocyte infections?
Publication Detail:
Type:  Journal Article; Review     Date:  2013-01-17
Journal Detail:
Title:  Bioengineered     Volume:  4     ISSN:  2165-5987     ISO Abbreviation:  Bioengineered     Publication Date:    2013 Nov-Dec
Date Detail:
Created Date:  2013-12-16     Completed Date:  2014-08-06     Revised Date:  2014-11-04    
Medline Journal Info:
Nlm Unique ID:  101581063     Medline TA:  Bioengineered     Country:  United States    
Other Details:
Languages:  eng     Pagination:  379-87     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Infective Agents / administration & dosage,  pharmacology*
Bioengineering
Biotechnology
Food Technology / methods*
Foodborne Diseases / prevention & control*
Humans
Models, Animal
Probiotics / administration & dosage,  pharmacology*
Stress, Physiological
Chemical
Reg. No./Substance:
0/Anti-Infective Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is a...
Next Document:  Occlusion Effect on in vivo Percutaneous Penetration of Chemicals in Man and Monkey: Partition Coeff...